Eastern Health

Futó vizsgálatok

• Toboroz

  Specific and Novel Approaches to Care of Inflammatory Bowel Disease During Pregnancy: the PREGO Study

  NCT07916727· Austin Health· Forrás

• Még nem toboroz

  Evaluating Ovarian Toxicity Outcomes Following Immunotherapy in Patients With Triple-Negative Breast Cancer (TNBC)

  NCT07527819· Peter MacCallum Cancer Centre, Australia· Forrás

• Toboroz

  Creating A Risk Assessment Tool for Thunderstorm Asthma: the CARISTA Study

  NCT07055542· University of Melbourne· Forrás

• Toboroz

  A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy

  NCT06963827· 3. fázis· Takeda· Forrás

• Toboroz

  Safety and Efficacy of OD-07656 and of Subsequent Vedolizumab Therapy in Moderately to Severely Active Ulcerative Colitis

  NCT06850727· 2. fázis· Odyssey Therapeutics, Inc.· Forrás

• Toboroz

  Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.

  NCT06697301· 2/3. fázis· Eikon Therapeutics· Forrás

• Toboroz

  A Study to Evaluate the Benefit of Adding Durvalumab After Chemotherapy, Durvalumab and Surgery in Patients With Early-stage, Operable, Non-small Cell Lung Cancer.

  NCT06284317· 3. fázis· ETOP IBCSG Partners Foundation· Forrás

• Fut, nem toboroz

  Subcutaneous Tirzepatide Once-weekly in Patients With Obesity and Knee Osteoarthritis (STOP KNEE-OA)

  NCT06191848· 4. fázis· University of Melbourne· Forrás

• Fut, nem toboroz

  A Trial to Learn if Fianlimab and Cemiplimab Are Safe and Work Better Than Anti-PD1 Alone in Adult Participants With Resectable Stage 3 or 4 Melanoma

  NCT06190951· 2. fázis· Regeneron Pharmaceuticals· Forrás

• Fut, nem toboroz

  A Trial to Learn if the Combination of Fianlimab, Cemiplimab, and Chemotherapy is Safe and Works Better Than the Combination of Cemiplimab and Chemotherapy in Adult Patients With Non-Small Cell Lung Cancer That Can be Treated With Surgery

  NCT06161441· 2. fázis· Regeneron Pharmaceuticals· Forrás

• Fut, nem toboroz

  Treatment Of Newly-diagnosed Follicular Lymphoma With CELMoD Golcadomide, Rituximab +/- Nivolumab.

  NCT05788081· 2. fázis· Olivia Newton-John Cancer Research Institute· Forrás

• Fut, nem toboroz

  Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease

  NCT05701358· Population Health Research Institute· Forrás

• Fut, nem toboroz

  Combining Sodium Valproate With Standard-of-care EGFR (Epidermal Growth Factor Receptor) Monoclonal Antibody Treatment in Patients With Metastatic Colorectal Cancer

  NCT05694936· 2. fázis· Australasian Gastro-Intestinal Trials Group· Forrás

• Fut, nem toboroz

  A Trial to See if the Combination of Fianlimab With Cemiplimab Works Better Than Pembrolizumab for Preventing or Delaying Melanoma From Coming Back After it Has Been Removed With Surgery

  NCT05608291· 3. fázis· Regeneron Pharmaceuticals· Forrás

• Toboroz

  The Australian HCV Point-of-Care Testing Program

  NCT05042544· Kirby Institute· Forrás

• Fut, nem toboroz

  RESOLUTE Trial Aims to Investigate the Value of Adding Local Ablative Treatment to Standard Systemic Treatment for Unresectable Oligometastatic Colorectal Cancer

  NCT05862051· Australasian Gastro-Intestinal Trials Group· Forrás

• Fut, nem toboroz

  Frontline Treatment of Follicular Lymphoma With AtezolizUmab and Obinutuzumab With and Without RadiOtherapy

  NCT04962126· 2. fázis· Olivia Newton-John Cancer Research Institute· Forrás

• Fut, nem toboroz

  A Phase 3 Study to Assess Efficacy and Safety of Tafasitamab Plus Lenalidomide and Rituximab Compared to Placebo Plus Lenalidomide and Rituximab in Patients With Relapsed/Refractory (R/R) Follicular Lymphoma or Marginal Zone Lymphoma.

  NCT04680052· 3. fázis· Incyte Corporation· Forrás

• Fut, nem toboroz

  Nivolumab Plus Rituximab in First-line Follicular Lymphoma gr 1-3A

  NCT03245021· 1. fázis· Dr. Eliza Hawkes· Forrás

• Fut, nem toboroz

  Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib.

  NCT03229200· 4. fázis· Pharmacyclics Switzerland GmbH· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Colitis ulcerosa2 toboroz
• Asztma1 toboroz
• Crohn-betegség1 toboroz
• Gyermekkori daganatok1 toboroz
• Hepatitis C1 toboroz
• IgA-nefropátia1 toboroz
• Melanóma1 toboroz
• Petefészekrák1 toboroz
• Tripla negatív emlőrák1 toboroz
• Tüdőrák1 toboroz

Lezárt vizsgálatok

• Leállították

  Open-label Extension for Phase 3 Clinical Trials of Simufilam

  NCT05575076· 3. fázis· Cassava Sciences, Inc.· Forrás

• Lezárult

  Simufilam 100 mg for Mild-to-Moderate Alzheimer's Disease

  NCT04994483· 3. fázis· Cassava Sciences, Inc.· Forrás

• Lezárult

  Feasibility Study of Induction and Maintenance Avelumab Plus R-CHOP in Patients With Diffuse DLBCL: The AvR-CHOP Study

  NCT03244176· Korai 1. fázis· Austin Health· Forrás

• Lezárult

  Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer

  NCT03072238· 3. fázis· Hoffmann-La Roche· Forrás

• Lezárult

  A Study of Avelumab With Axitinib Versus Sunitinib In Advanced Renal Cell Cancer (JAVELIN Renal 101)

  NCT02684006· 3. fázis· Pfizer· Forrás

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Cannabis use disorder12 munka · 0 vizsgálat
• Borderline personality disorder11 munka · 0 vizsgálat
• Alcohol use disorder10 munka · 0 vizsgálat
• Cocaine and methamphetamine use disorder3 munka · 0 vizsgálat